SPONSOR
Tianjin Medical University
Total Trials
8
Recruiting
8
Phases
N/A
Conditions studied: CXCR4-related DiseaseTumorPositron Emission TomographyMetastasisSympathetic Nervous System DiseasesSympathetic Nervous Structure InjurySympathetic Nerve InjuryPSMA-related DiseaseProstate CancerFAP
Tianjin Medical University is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Tianjin Medical University
How many clinical trials has Tianjin Medical University sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Tianjin Medical University, of which 8 are actively recruiting participants. These trials cover conditions including CXCR4-related Disease, Tumor, Positron Emission Tomography. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Tianjin Medical University research focus on?
Tianjin Medical University clinical trials span CXCR4-related Disease, Tumor, Positron Emission Tomography, Metastasis, Sympathetic Nervous System Diseases, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Tianjin Medical University clinical trial?
To participate in a Tianjin Medical University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Tianjin Medical University trials with current recruitment status updated daily.
Clinical Trials by Tianjin Medical University
NCT06690736
Recruiting
Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases
CXCR4-related Disease
NCT06951984
Recruiting
Hydroxyephedrine PET/CT in Sympathetic Nervous System Disease
Sympathetic Nervous System Diseases
NCT06690970
Recruiting
Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients
PSMA-related Disease
NCT07306598
Recruiting
[18F]NIDF PET Imaging in Tau-related Diseases
Neurodegenerative Disease
NCT07685873
Recruiting
Monoamine Oxidase B PET/CT in Various MAO-B-Related Disease
Parkinson Disease
NCT07130565
Recruiting
Pan-Amyloid PET/CT in Various Amyloid-Related Disease
Amyloid
NCT06690983
Recruiting
Tau PET/CT in Various Tau-Related Disease Patients
Tauopathies
NCT06725719
Recruiting
Translocator Protein PET/CT in Various TSPO-Related Disease
Neuroinflammation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology